Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 39 min ago
Peer-reviewedCC BY-NC-NDInternal Medicine

A Refractory Deep Gastric Ulcer after Proton Beam Therapy

  • Hayato Fujita
  • Tsuyoshi Suda
  • Kenkei Hasatani
  • Hiroyuki Aoyagi
Read full textPDFDOICite

Abstract

Picture 1. Picture 2. Picture 3. Picture 4. A 46-year-old man with locally advanced pancreatic head cancer underwent gemcitabine-concurrent proton beam therapy (2.0 GyE ×25 fractions; total dose: 50.0 GyE).He had no history of nonsteroidal anti-inflammatory drug use and tested negative for Helicobacter pylori.The patient presented with mild abdominal pain.Mucosal disruption and wall thinning in

Related

  1. The efficacy and safety of dupilumab therapy in pediatric patients with refractory eosinophilic duodenal bulb ulcer: a retrospective cohort study
    Zhiheng Huang, Ping Li, Ying Zhou +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossref
  2. Planned Distal Pancreatectomy and Splenectomy for Pancreatic Tail Necrosis and Splenic Infarction after Embolization for Gastric Ulcer-Induced Splenic Artery Perforation: A Case Report.
    Yasutaka Saito, Kazuki Masiko, Taichiro Ueda +1
    Surgical case reportsPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. Late Delayed Bleeding After Gastric ESD with Esomeprazole/Sodium Bicarbonate Versus Conventional Esomeprazole, and Artificial Ulcer Healing with Esomeprazole/Sodium Bicarbonate: A Retrospective Cohort Study
    Hyeong-Seok Nam, Dae-Gon Ryu, Su-Jin Kim +6
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  4. Perforated marginal ulcer after Roux-en-Y gastric bypass: a national analysis of operative approaches, outcomes, and practice variations, 2018–2022
    Wael Alkattan
    Frontiers in SurgeryPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  5. PRIMARY GASTRIC PLASMABLASTIC LYMPHOMA FOLLOWING ANTIRETROVIRAL THERAPY INTERRUPTION IN A PATIENT WITH PREVIOUSLY TREATED GASTRIC DIFFUSE LARGE B-CELL LYMPHOMA: A REFRACTORY CASE REPORT
    Laysa Andrade RADTKE, Felipe Andreani Camargo MANDUCO, Fernando CALLERA
    Hematology, Transfusion and Cell TherapyPeer-reviewedCC BYFull textOncologyDOAJ

Cite

BibTeXRIS
BibTeX
@article{fujita2026refractory,
  title = {{A Refractory Deep Gastric Ulcer after Proton Beam Therapy}},
  author = {Hayato Fujita and Tsuyoshi Suda and Kenkei Hasatani and Hiroyuki Aoyagi},
  journal = {Internal Medicine},
  year = {2026},
  month = aug,
  doi = {10.2169/internalmedicine.7584-26},
  url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7584-26/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - A Refractory Deep Gastric Ulcer after Proton Beam Therapy
AU  - Hayato Fujita
AU  - Tsuyoshi Suda
AU  - Kenkei Hasatani
AU  - Hiroyuki Aoyagi
PY  - 2026
DA  - 2026/08/25
JO  - Internal Medicine
DO  - 10.2169/internalmedicine.7584-26
UR  - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7584-26/_article
AB  - Picture 1. Picture 2. Picture 3. Picture 4. A 46-year-old man with locally advanced pancreatic head cancer underwent gemcitabine-concurrent proton beam therapy (2.0 GyE ×25 fractions; total dose: 50.0 GyE).He had no history of nonsteroidal anti-inflammatory drug use and tested negative for Helicobacter pylori.The patient presented with mild abdominal pain.Mucosal disruption and wall thinning in
SN  - 1349-7235
SN  - 0918-2918
ER  -